본문 바로가기
KERD
논문KCI 등재

Changes in Pre- and Post-Electroconvulsive Therapy Serum Myostatin Levels in Patients with Treatment Resistant Depression

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objective: Myostatin is a growth factor which is investigated regarding musculoskeletal system. Albeit its effect on muscle mass is known, it is considered likely having other unknown effects as well, particularly on central nervous system. With this study, it is aimed to find out that what type of effect electroconvulsive therapy (ECT) does on myostatin in patients with treatment resistant depression. Methods: Twenty-nine patients with treatment resistant major depression and thirty healthy volunteers were included in the study. Pre- and post-ECT levels of myostatine were compared; also this results were compared to healthy controls. Results: For 29 patients with treatment-resistant major depression, the pre-treatment mean myostatin level was 0.95±0.32 ng/ml and post-therapy myostatin level was 11.05±6.97 ng/ml. As a result of this study, it is found that ECT affects serum myostatin levels to a significant degree (t=4.17, p<0.05). It is also found that there was a significant relation between serum myostatin levels and depression scores (r=0.392, p<0.05). Conclusion: With the present study and similar ones, it can be understood that how ECT achieves its effectiveness biologically.

Abstract

Objective: Myostatin is a growth factor which is investigated regarding musculoskeletal system. Albeit its effect on muscle mass is known, it is considered likely having other unknown effects as well, particularly on central nervous system. With this study, it is aimed to find out that what type of effect electroconvulsive therapy (ECT) does on myostatin in patients with treatment resistant depression. Methods: Twenty-nine patients with treatment resistant major depression and thirty healthy volunteers were included in the study. Pre- and post-ECT levels of myostatine were compared; also this results were compared to healthy controls. Results: For 29 patients with treatment-resistant major depression, the pre-treatment mean myostatin level was 0.95±0.32 ng/ml and post-therapy myostatin level was 11.05±6.97 ng/ml. As a result of this study, it is found that ECT affects serum myostatin levels to a significant degree (t=4.17, p<0.05). It is also found that there was a significant relation between serum myostatin levels and depression scores (r=0.392, p<0.05). Conclusion: With the present study and similar ones, it can be understood that how ECT achieves its effectiveness biologically.

참고문헌 (31)

  1. Lee SJ, "Myostatin and the control of skeletal muscle mass", Curr Opin Genet Dev, 9, pp.604~607 (1999)
  2. Sharma M, "Myostatin in muscle growth and repair", Exerc Sport Sci Rev, 29, pp.155~158 (2001)
  3. Tsuchida K, "Targeting myostatin for therapies against muscle-wasting disorders", Curr Opin Drug Discov Devel, 11, pp.487~494 (2008)
  4. Kollias HD, "Transforming growth factor-beta and myostatin signaling in skeletal muscle", J Appl Physiol(1985), 104, pp.579~587 (2008)
  5. Huang Z, "Myostatin : a novel insight into its role in metabolism, signal pathways, and expression regulation", Cell Signal, 23, pp.1441~1446 (2011)
  6. Han HQ, "Targeting the myostatin signaling pathway to treat muscle wasting diseases", Curr Opin Support Palliat Care, 5, pp.334~341 (2011)
  7. Filonzi L, "The potential role of myostatin and neurotransmission genes in elite sport performances", J Biosci, 40, pp.531~537 (2015)
  8. Guo M, "Role of the adipose PPAR-adiponectin axis in susceptibility to stress and depression", anxiety-related behaviors, 2017, pp.22, 1056~1068
  9. Chan JS, "Adiponectin potentially contributes to the antidepressive effects of Baduanjin Qigong exercise in women with chronic fatigue syndrome-like illness", Cell Transplant, 26, pp.493~501 (2017)
  10. Gruson D, "Increased plasma myostatin in heart failure", Eur J Heart Fail, 13, pp.734~736 (2011)
  11. Lenk K, "Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure", Eur J Prev Cardiol, 19, pp.404~411 (2012)
  12. Coffey VG, "Interaction of contractile activity and training history on mRNA abundance in skeletal muscle from trained athletes", Am J Physiol Endocrinol Metab, 290, pp.E849~ (2006)[DOI]
  13. Costa A, "Impact of repeated bouts of eccentric exercise on myogenic gene expression", Eur J Appl Physiol, 101, pp.427~436 (2007)
  14. Russo TL, "Stretching and electrical stimulation reduce the accumulation of MyoD, myostatin and atrogin-1 in denervated rat skeletal muscle", J Muscle Res Cell Motil, 31, pp.45~57 (2010)
  15. Polyakova M, "Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy : systematic review and meta-analyses of the preclinical and clinical literature", PLoS One, 10, pp.e0141564~ (2015)
  16. Allen AP, "Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response : A comparison of ketamine and ECT", J Affect Disord, 186, pp.306~311 (2015)
  17. Angelucci F, "Electroconvulsive stimuli alter nerve growth factor but not brain-derived neurotrophic factor concentrations in brains of a rat model of depression", Neuropeptides, 37, pp.51~56 (2003)
  18. Nikisch G, "CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy", Eur Psychiatry, 23, pp.356~359 (2008)
  19. Kragh J, "Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals", Exp Brain Res, 98, pp.305~313 (1994)
  20. Amit Singh, "How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms", Clinical Psychopharmacology and Neuroscience, 15(3), pp.210~221 (2017), 대한정신약물학회[DOI]
  21. Thase ME, "When at first you don't succeed : sequential strategies for antidepressant nonresponders", J Clin Psychiatry, 58(Suppl 13), pp.23~29 (1997)
  22. Hisli N, "Validity and reliability of Beck Depression Scale in university students", Turk J Psychol, 7, pp.13~19 (1989)
  23. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (A task force report of the American Psychiatric Association), "American Psychiatric Association", American Psychiatric Pub, ~ (2000)
  24. Suzuki ST, "Enhanced muscle by myostatin propeptide increases adipose tissue adiponectin, PPAR-alpha, and PPAR-gamma expressions", Biochem Biophys Res Commun, 369, pp.767~773 (2008)
  25. Fry M, "Area postrema neurons are modulated by the adipocyte hormone adiponectin", J Neurosci, 26, pp.9695~9702 (2006)
  26. Liu J, "Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity", Proc Natl Acad Sci U S A, 109, pp.12248~12253 (2012)
  27. Segi-Nishida E, "Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus", Proc Natl Acad Sci U S A, 105, pp.11352~11357 (2008)
  28. Evans SJ, "Dysregulation of the fibroblast growth factor system in major depression", Proc Natl Acad Sci U S A, 101, pp.15506~15511 (2004)
  29. Madsen TM, "Increased neurogenesis in a model of electroconvulsive therapy", Biol Psychiatry, 47, pp.1043~1049 (2000)
  30. Yau SY, "Physical exercise-induced hippocampal neurogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectin", Proc Natl Acad Sci U S A, 111, pp.15810~15815 (2014)
  31. Sitzmann AF, "Treatment-resistant cepression, obesity, and adiponectin", pp.2015

관련 논문AI추천

Evaluation of Oxidative Status in Patients Treated with Electroconvulsive TherapyAli Korkmaz, Bunyamin Kaptanoglu, Hasan Herken, Hulya Aybek, Mahmut Şenyurt대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2017 · 제15권 제1호Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart ReviewAsuka Katsuki, Atsuko Ikenouchi-Sugita, Hikaru Hori, Jun Nakamura, Kenji Hayashi, Kiyokazu Atake, Reiji Yoshimura, Takahiro Shinkai, Tatsuya Okamoto, Wakako Umene-Nakano, Yuki Tokutsu대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2013 · 제11권 제1호Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive DisorderBun-Hee Lee, Young-Min Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2018 · 제15권 제8호Recent Updates on Electro-Convulsive Therapy in Patients with Depression전홍진, Chung In Won, Kim Eun Ji, Kim Hyewon, Lee Sang Min, Park Mi Jin, Vidal Yook대한신경정신의학회 · PSYCHIATRY INVESTIGATION2021 · 제18권 제1호How Electroconvulsive Therapy Works?: Understanding the Neurobiological MechanismsAmit Singh, Sujita Kumar Kar대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2017 · 제15권 제3호Evaluating the Levels of Nesfatin-1 and Ghrelin Hormones in Patients with Moderate and Severe Major Depressive DisordersOguz Ozcelik, Sermin Algul대한신경정신의학회 · PSYCHIATRY INVESTIGATION2018 · 제15권 제2호

이 간행물의 다른 논문 (16건)